<VariationArchive RecordType="classified" VariationID="162493" VariationName="NR_002196.1(H19):n.-7080_-1781del" VariationType="Deletion" Accession="VCV000162493" Version="1" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2015-01-18" MostRecentSubmission="2015-01-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="172167" VariationID="162493">
      <GeneList>
        <Gene Symbol="H19" FullName="H19 imprinted maternally expressed transcript" GeneID="283120" HGNC_ID="HGNC:4713" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="1995176" stop="2001466" display_start="1995176" display_stop="2001466" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_021160004.1" start="187698" stop="193988" display_start="187698" display_stop="193988" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2016405" stop="2019064" display_start="2016405" display_stop="2019064" Strand="-" />
          </Location>
          <OMIM>103280</OMIM>
          <Haploinsufficiency last_evaluated="2012-03-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=H19">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-03-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=H19">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="H19-ICR" FullName="H19/IGF2 imprinting control region" GeneID="105259599" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="1998202" stop="2003509" display_start="1998202" display_stop="2003509" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_021160004.1" start="190724" stop="196031" display_start="190724" display_stop="196031" Strand="+" />
          </Location>
          <OMIM>616186</OMIM>
        </Gene>
        <Gene Symbol="MRPL23" FullName="mitochondrial ribosomal protein L23" GeneID="6150" HGNC_ID="HGNC:10322" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="1947332" stop="2014944" display_start="1947332" display_stop="2014944" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_021160004.1" start="139854" stop="207466" display_start="139854" display_stop="207466" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="1968501" stop="1977838" display_start="1968501" display_stop="1977838" Strand="+" />
          </Location>
          <OMIM>600789</OMIM>
        </Gene>
      </GeneList>
      <Name>NR_002196.1(H19):n.-7080_-1781del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" outerStart="1999616" innerStart="1999620" innerStop="2004915" outerStop="2004919" display_start="1999616" display_stop="2004919" variantLength="5296" />
      </Location>
      <OtherNameList>
        <Name>5.3-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.(1999616_1999620)_(2004915_2004919)del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.(1999616_1999620)_(2004915_2004919)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv7487189" DB="dbVar" />
        <XRef ID="nsv1197591" DB="dbVar" />
        <XRef Type="Allelic variant" ID="616186.0002" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">A 5.3 kb deletion from the H19/IGF2 imprinting control region.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NR_002196.1(H19):n.-7080_-1781del AND Wilms tumor 2" Accession="RCV000149876" Version="3">
        <ClassifiedConditionList TraitSetID="6168">
          <ClassifiedCondition DB="MedGen" ID="C3887743">Wilms tumor 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NR_002196.1(H19):n.-7080_-1781del AND Beckwith-Wiedemann syndrome" Accession="RCV000149877" Version="3">
        <ClassifiedConditionList TraitSetID="1134">
          <ClassifiedCondition DB="MedGen" ID="C0004903">Beckwith-Wiedemann syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-11-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2015-01-18" MostRecentSubmission="2015-01-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18836444</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6168" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6124" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial Wilms tumor 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wilms tumor 2</ElementValue>
                <XRef ID="Familial+Wilms+Tumor+2/2778" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008680" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WT2</ElementValue>
                <XRef Type="MIM" ID="194071" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8559" />
                <XRef ID="8559" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <XRef ID="654" DB="Orphanet" />
              <XRef ID="C3887743" DB="MedGen" />
              <XRef ID="MONDO:0008680" DB="MONDO" />
              <XRef Type="MIM" ID="194071" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1134" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="589" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
                <XRef ID="Beckwith-Wiedemann+Syndrome/774" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007534" DB="MONDO" />
                <XRef ID="81780002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Exomphalos macroglossia gigantism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EMG Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BWS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WBS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which affected individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</Attribute>
                <XRef ID="NBK1394" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3343" />
                <XRef ID="3343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301568</ID>
                <ID Source="BookShelf">NBK1394</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="general" Abbrev="Italian BWS Association, 2016">
                <ID Source="PubMed">26592461</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="116" DB="Orphanet" />
              <XRef ID="C0004903" DB="MedGen" />
              <XRef ID="MONDO:0007534" DB="MONDO" />
              <XRef Type="MIM" ID="130650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="354463" SubmissionDate="2015-01-15" DateLastUpdated="2015-01-18" DateCreated="2015-01-18">
        <ClinVarSubmissionID localKey="616186.0002_WILMS TUMOR 2" title="ICR1, 5.3-KB DEL      _WILMS TUMOR 2" />
        <ClinVarAccession Accession="SCV000196730" DateUpdated="2015-01-18" DateCreated="2015-01-18" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with isolated Wilms tumor (194071), Scott et al. (2008) identified a 5.3-kb deletion encompassing all but the telomeric 200 bp of the H19 DMR repeat block, resulting in hypermethylation. The mutation deleted 6 of 7 CTCF (604167) target sites. The mutation was inherited from the unaffected mother. A sib with overgrowth features of Beckwith-Wiedemann syndrome (130650) also carried the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">18836444</ID>
              </Citation>
              <XRef DB="OMIM" ID="194071" Type="MIM" />
              <XRef DB="OMIM" ID="604167" Type="MIM" />
              <XRef DB="OMIM" ID="130650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ICR1" />
          </GeneList>
          <Name>ICR1, 5.3-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5.3-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="616186.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WILMS TUMOR 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="354464" SubmissionDate="2015-01-15" DateLastUpdated="2015-01-18" DateCreated="2015-01-18">
        <ClinVarSubmissionID localKey="616186.0002_BECKWITH-WIEDEMANN SYNDROME" title="ICR1, 5.3-KB DEL      _BECKWITH-WIEDEMANN SYNDROME" />
        <ClinVarAccession Accession="SCV000196731" DateUpdated="2015-01-18" DateCreated="2015-01-18" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with isolated Wilms tumor (194071), Scott et al. (2008) identified a 5.3-kb deletion encompassing all but the telomeric 200 bp of the H19 DMR repeat block, resulting in hypermethylation. The mutation deleted 6 of 7 CTCF (604167) target sites. The mutation was inherited from the unaffected mother. A sib with overgrowth features of Beckwith-Wiedemann syndrome (130650) also carried the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">18836444</ID>
              </Citation>
              <XRef DB="OMIM" ID="194071" Type="MIM" />
              <XRef DB="OMIM" ID="604167" Type="MIM" />
              <XRef DB="OMIM" ID="130650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ICR1" />
          </GeneList>
          <Name>ICR1, 5.3-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5.3-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="616186.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BECKWITH-WIEDEMANN SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="354464" TraitType="Disease" MappingType="Name" MappingValue="BECKWITH-WIEDEMANN SYNDROME" MappingRef="Alternate">
        <MedGen CUI="C0004903" Name="Beckwith-Wiedemann syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="354463" TraitType="Disease" MappingType="Name" MappingValue="WILMS TUMOR 2" MappingRef="Preferred">
        <MedGen CUI="C3887743" Name="Wilms tumor 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

